Mitchell Ms
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
Papers in
-
- Immunotherapy and Immune Responses 8
- Oncology 7
- Cancer Immunotherapy and Biomarkers 3
- Cancer Diagnosis and Treatment 2
- Co-authors
- Bertino (3 shared papers)Papac Rj (2 shared papers)Martin Levitt (2 shared papers)Thomas Ed (1 shared paper)Rose J. Papac (1 shared paper)Kaplan (1 shared paper)Philip B. Mitchell (1 shared paper)Kirkwood Jm (1 shared paper)
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (20 papers)
- Partner nations
- United StatesAustralia
In The Last Decade
Mitchell Ms
19 papers receiving 377 citations
Peers
Comparison fields: 5 of 81
- Immunology 151
- Otorhinolaryngology 29
- Oncology 177
- Hematology 46
- Dermatology 23
Countries citing papers authored by Mitchell Ms
This map shows the geographic impact of Mitchell Ms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Ms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Ms more than expected).
Fields of papers citing papers by Mitchell Ms
This network shows the impact of papers produced by Mitchell Ms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Ms. The network helps show where Mitchell Ms may publish in the future.
Co-authors
The 18 scholars most cited alongside Mitchell Ms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Improved therapeutic index of methotrexate with "leucovorin rescue". | 1973 | 123 |
| 2 | Perspective on allogeneic melanoma lysates in active specific immunotherapy. | 1998 | 82 |
| 3 | Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck. | 1968 | 48 |
| 4 | Chemotherapy in combination with biomodulation: a 5-year experience with cyclophosphamide and interleukin-2. | 1992 | 29 |
| 5 | Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities. | 1982 | 22 |
| 6 | Cell-mediated immunity and blocking factor in ovarian carcinoma. | 1976 | 21 |
| 7 | Recombinant interferon alpha-2 (INTRON A) in a phase II study of renal cell carcinoma. | 1986 | 19 |
| 8 | Metabolism of methotrexate in man after high and conventional doses. | 1980 | 15 |
| 9 | The management of depression. Part 2. The place of the new antidepressants. | 1994 | 9 |
| 10 | New trends in the development of cancer vaccines. | 1999 | 9 |
| 11 | Transient warm autoimmune hemolytic anemia and cryoglobulinemia associated with seminoma. | 1977 | 8 |
| 12 | Staphylococcal protein A immunoadsorptive column induces mitogenicity in perfused plasma. | 1984 | 7 |
| 13 | The effect of bioburden on in-depth disinfection of denture base acrylic resin. | 1998 | 6 |
| 14 | Studies on the immunogical effects of BCG and its components: theoritical and therapeutic implications. | 1976 | 5 |
| 15 | Pulmonary granulomas in a patient on MER therapy. | 1978 | 3 |
| 16 | The Yale combination chemotherapy program for advanced Hodgkin's disease. A preliminary report. | 1970 | 2 |
| 17 | Active specific immunotherapy of melanoma: clinical results and correlates. | 1993 | 2 |
| 18 | Active specific immunotherapy in the treatment of human cancers. | 1989 | 2 |
| 19 | A personal (biased) perspective on cancer "vaccines". | 1997 | 2 |
| 20 | Regarding breast cancer as an immunologically responsive tumor. | 1995 | 1 |
About Mitchell Ms
Mitchell Ms is a scholar working on Immunology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 21 papers that have together received 415 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers), vaccines and immunoinformatics approaches (3 papers), Head and Neck Cancer Studies (2 papers), Lymphoma Diagnosis and Treatment (2 papers), RNA Interference and Gene Delivery (2 papers) and Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Immunology (151 citations), Otorhinolaryngology (29 citations), Oncology (177 citations), Hematology (46 citations) and Dermatology (23 citations). Mitchell Ms has collaborated with scholars based in United States and Australia. Frequent co-authors include Bertino, Papac Rj, Martin Levitt, Thomas Ed, Rose J. Papac, Kaplan, Philip B. Mitchell, Kirkwood Jm, Stephan Ariyan and D. Farquhar. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.